The rs4712527 Polymorphism in the CDKAL1 Gene: A protective factor for proliferative diabetic retinopathy progress in type 2 diabetes

Autores
Yang, Pablo; Luna, José Domingo; Alcoba, Emilio; Sein, Aylén; Gramajo, Ana Laura; Juárez, Claudio P.; Beltramo, Dante Miguel; Soria, Néstor Walter
Año de publicación
2018
Idioma
inglés
Tipo de recurso
artículo
Estado
versión publicada
Descripción
Purpose: Diabetic retinopathy (DR) is one of the chronic retinal disorders linked to diabetes and remains the leading cause of blindness in working-age people. Many studies have demonstrated the existence of associations between type 2 diabetes mellitus (T2DM) and variants in the cyclin-dependent kinase 5 regulatory subunit?associated protein 1-like 1 (CDKAL1) gene. Here, weperformed a case-control study in the CDKAL1 gene (rs4712527 polymorphism) to investigate the potential association between this single-nucleotide polymorphism (SNP) and DR risk. Methods: Two hundred thirty-one patients with T2DM (126 patients with proliferative diabetic retinopathy [PDR] and 105 patients without diabetic retinopathy [WDR]), who assisted at the CentroPrivado de Ojos Romagosa, Fundacio´n VER, were studied. An independent cohort of 98 patients (56 with PDR and 42 with WDR) from the Hospital Nacional de Clı´nicas was taken for replication. A complete ophthalmological examination included an externalexamination of the eye and adnexa, pupil responsiveness, and slit-lamp biomicroscopic examination. Genotyping of rs4712527 was carried out by polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP). The odds ratio (OR) and 95% CI were calculated by unconditional logistic regression adjusted for diabetes duration, body mass index, insulin therapy,HbA1c, total cholesterol, high-density lipoprotein cholesterol, low-density lipoprotein cholesterol, triglycerides, and systolic and diastolic blood pressure. Results: Analysis from the rs4712527 SNP in the Centro Privado de Ojos Romagosa, Fundacio´n VER, cohort was found to be associated with decreased risk of PDR both before and after adjustment, under the codominant (adjustedOR ¼ 0.16 [95% CI, 0.06-0.44]; P ¼ 4e-04), dominant (adjusted OR ¼ 0.17 [95% CI, 0.07-0.43]; P ¼ 1e-04), overdominant (adjusted OR ¼ 0.20 [95% CI, 0.08-0.52]; P ¼ 5e-04), and log-additive (adjusted OR ¼ 0.28 [95% CI, 0.13-0.59]; P ¼ 4e-04)models. In the combined analysis including both cohorts, the rs4712527 was nominally involved as a protective factor in the development of DR. Conclusions: Our findings suggest that the rs4712527 in the CDKAL1 gene might be involved in the protection to develop PDR in T2DM.
Fil: Yang, Pablo. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Córdoba; Argentina. Universidad Católica de Córdoba. Facultad de Ciencias Químicas; Argentina. Area de Ciencias Agrarias, Ingeniería, Ciencias Biológicas y de la Salud de la Universidad Católica de Córdoba; Argentina
Fil: Luna, José Domingo. Fundaciòn Ver; Argentina
Fil: Alcoba, Emilio. Fundaciòn Ver; Argentina
Fil: Sein, Aylén. Fundaciòn Ver; Argentina
Fil: Gramajo, Ana Laura. Fundaciòn Ver; Argentina
Fil: Juárez, Claudio P.. Fundaciòn Ver; Argentina
Fil: Beltramo, Dante Miguel. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Córdoba; Argentina. Provincia de Córdoba. Ministerio de Ciencia y Técnica. Centro de Excelencia en Productos y Procesos de Córdoba; Argentina. Universidad Católica de Córdoba. Facultad de Ciencias Químicas; Argentina. Area de Ciencias Agrarias, Ingeniería, Ciencias Biológicas y de la Salud de la Universidad Católica de Córdoba; Argentina
Fil: Soria, Néstor Walter. Universidad Católica de Córdoba. Facultad de Ciencias Químicas; Argentina. Area de Ciencias Agrarias, Ingeniería, Ciencias Biológicas y de la Salud de la Universidad Católica de Córdoba; Argentina
Materia
CDKAL1 GENE
POLYMORPHISM
RS4712527
DIABETIC RETINOPATHY
TYPE 2 DIABETES
Nivel de accesibilidad
acceso abierto
Condiciones de uso
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
Repositorio
CONICET Digital (CONICET)
Institución
Consejo Nacional de Investigaciones Científicas y Técnicas
OAI Identificador
oai:ri.conicet.gov.ar:11336/164341

id CONICETDig_3fc1c2832e6d233fdc21db020bfd4a71
oai_identifier_str oai:ri.conicet.gov.ar:11336/164341
network_acronym_str CONICETDig
repository_id_str 3498
network_name_str CONICET Digital (CONICET)
spelling The rs4712527 Polymorphism in the CDKAL1 Gene: A protective factor for proliferative diabetic retinopathy progress in type 2 diabetesYang, PabloLuna, José DomingoAlcoba, EmilioSein, AylénGramajo, Ana LauraJuárez, Claudio P.Beltramo, Dante MiguelSoria, Néstor WalterCDKAL1 GENEPOLYMORPHISMRS4712527DIABETIC RETINOPATHYTYPE 2 DIABETEShttps://purl.org/becyt/ford/3.2https://purl.org/becyt/ford/3Purpose: Diabetic retinopathy (DR) is one of the chronic retinal disorders linked to diabetes and remains the leading cause of blindness in working-age people. Many studies have demonstrated the existence of associations between type 2 diabetes mellitus (T2DM) and variants in the cyclin-dependent kinase 5 regulatory subunit?associated protein 1-like 1 (CDKAL1) gene. Here, weperformed a case-control study in the CDKAL1 gene (rs4712527 polymorphism) to investigate the potential association between this single-nucleotide polymorphism (SNP) and DR risk. Methods: Two hundred thirty-one patients with T2DM (126 patients with proliferative diabetic retinopathy [PDR] and 105 patients without diabetic retinopathy [WDR]), who assisted at the CentroPrivado de Ojos Romagosa, Fundacio´n VER, were studied. An independent cohort of 98 patients (56 with PDR and 42 with WDR) from the Hospital Nacional de Clı´nicas was taken for replication. A complete ophthalmological examination included an externalexamination of the eye and adnexa, pupil responsiveness, and slit-lamp biomicroscopic examination. Genotyping of rs4712527 was carried out by polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP). The odds ratio (OR) and 95% CI were calculated by unconditional logistic regression adjusted for diabetes duration, body mass index, insulin therapy,HbA1c, total cholesterol, high-density lipoprotein cholesterol, low-density lipoprotein cholesterol, triglycerides, and systolic and diastolic blood pressure. Results: Analysis from the rs4712527 SNP in the Centro Privado de Ojos Romagosa, Fundacio´n VER, cohort was found to be associated with decreased risk of PDR both before and after adjustment, under the codominant (adjustedOR ¼ 0.16 [95% CI, 0.06-0.44]; P ¼ 4e-04), dominant (adjusted OR ¼ 0.17 [95% CI, 0.07-0.43]; P ¼ 1e-04), overdominant (adjusted OR ¼ 0.20 [95% CI, 0.08-0.52]; P ¼ 5e-04), and log-additive (adjusted OR ¼ 0.28 [95% CI, 0.13-0.59]; P ¼ 4e-04)models. In the combined analysis including both cohorts, the rs4712527 was nominally involved as a protective factor in the development of DR. Conclusions: Our findings suggest that the rs4712527 in the CDKAL1 gene might be involved in the protection to develop PDR in T2DM.Fil: Yang, Pablo. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Córdoba; Argentina. Universidad Católica de Córdoba. Facultad de Ciencias Químicas; Argentina. Area de Ciencias Agrarias, Ingeniería, Ciencias Biológicas y de la Salud de la Universidad Católica de Córdoba; ArgentinaFil: Luna, José Domingo. Fundaciòn Ver; ArgentinaFil: Alcoba, Emilio. Fundaciòn Ver; ArgentinaFil: Sein, Aylén. Fundaciòn Ver; ArgentinaFil: Gramajo, Ana Laura. Fundaciòn Ver; ArgentinaFil: Juárez, Claudio P.. Fundaciòn Ver; ArgentinaFil: Beltramo, Dante Miguel. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Córdoba; Argentina. Provincia de Córdoba. Ministerio de Ciencia y Técnica. Centro de Excelencia en Productos y Procesos de Córdoba; Argentina. Universidad Católica de Córdoba. Facultad de Ciencias Químicas; Argentina. Area de Ciencias Agrarias, Ingeniería, Ciencias Biológicas y de la Salud de la Universidad Católica de Córdoba; ArgentinaFil: Soria, Néstor Walter. Universidad Católica de Córdoba. Facultad de Ciencias Químicas; Argentina. Area de Ciencias Agrarias, Ingeniería, Ciencias Biológicas y de la Salud de la Universidad Católica de Córdoba; ArgentinaSAGE Publications2018-05info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttp://purl.org/coar/resource_type/c_6501info:ar-repo/semantics/articuloapplication/pdfapplication/pdfapplication/pdfapplication/pdfhttp://hdl.handle.net/11336/164341Yang, Pablo; Luna, José Domingo; Alcoba, Emilio; Sein, Aylén; Gramajo, Ana Laura; et al.; The rs4712527 Polymorphism in the CDKAL1 Gene: A protective factor for proliferative diabetic retinopathy progress in type 2 diabetes; SAGE Publications; Journal of VitreoRetinal Diseases; 2; 4; 5-2018; 1-82474-12642474-1272CONICET DigitalCONICETenginfo:eu-repo/semantics/altIdentifier/url/http://journals.sagepub.com/doi/10.1177/2474126418777405info:eu-repo/semantics/altIdentifier/doi/10.1177/2474126418777405info:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by-nc-sa/2.5/ar/reponame:CONICET Digital (CONICET)instname:Consejo Nacional de Investigaciones Científicas y Técnicas2025-09-29T09:51:17Zoai:ri.conicet.gov.ar:11336/164341instacron:CONICETInstitucionalhttp://ri.conicet.gov.ar/Organismo científico-tecnológicoNo correspondehttp://ri.conicet.gov.ar/oai/requestdasensio@conicet.gov.ar; lcarlino@conicet.gov.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:34982025-09-29 09:51:17.76CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicasfalse
dc.title.none.fl_str_mv The rs4712527 Polymorphism in the CDKAL1 Gene: A protective factor for proliferative diabetic retinopathy progress in type 2 diabetes
title The rs4712527 Polymorphism in the CDKAL1 Gene: A protective factor for proliferative diabetic retinopathy progress in type 2 diabetes
spellingShingle The rs4712527 Polymorphism in the CDKAL1 Gene: A protective factor for proliferative diabetic retinopathy progress in type 2 diabetes
Yang, Pablo
CDKAL1 GENE
POLYMORPHISM
RS4712527
DIABETIC RETINOPATHY
TYPE 2 DIABETES
title_short The rs4712527 Polymorphism in the CDKAL1 Gene: A protective factor for proliferative diabetic retinopathy progress in type 2 diabetes
title_full The rs4712527 Polymorphism in the CDKAL1 Gene: A protective factor for proliferative diabetic retinopathy progress in type 2 diabetes
title_fullStr The rs4712527 Polymorphism in the CDKAL1 Gene: A protective factor for proliferative diabetic retinopathy progress in type 2 diabetes
title_full_unstemmed The rs4712527 Polymorphism in the CDKAL1 Gene: A protective factor for proliferative diabetic retinopathy progress in type 2 diabetes
title_sort The rs4712527 Polymorphism in the CDKAL1 Gene: A protective factor for proliferative diabetic retinopathy progress in type 2 diabetes
dc.creator.none.fl_str_mv Yang, Pablo
Luna, José Domingo
Alcoba, Emilio
Sein, Aylén
Gramajo, Ana Laura
Juárez, Claudio P.
Beltramo, Dante Miguel
Soria, Néstor Walter
author Yang, Pablo
author_facet Yang, Pablo
Luna, José Domingo
Alcoba, Emilio
Sein, Aylén
Gramajo, Ana Laura
Juárez, Claudio P.
Beltramo, Dante Miguel
Soria, Néstor Walter
author_role author
author2 Luna, José Domingo
Alcoba, Emilio
Sein, Aylén
Gramajo, Ana Laura
Juárez, Claudio P.
Beltramo, Dante Miguel
Soria, Néstor Walter
author2_role author
author
author
author
author
author
author
dc.subject.none.fl_str_mv CDKAL1 GENE
POLYMORPHISM
RS4712527
DIABETIC RETINOPATHY
TYPE 2 DIABETES
topic CDKAL1 GENE
POLYMORPHISM
RS4712527
DIABETIC RETINOPATHY
TYPE 2 DIABETES
purl_subject.fl_str_mv https://purl.org/becyt/ford/3.2
https://purl.org/becyt/ford/3
dc.description.none.fl_txt_mv Purpose: Diabetic retinopathy (DR) is one of the chronic retinal disorders linked to diabetes and remains the leading cause of blindness in working-age people. Many studies have demonstrated the existence of associations between type 2 diabetes mellitus (T2DM) and variants in the cyclin-dependent kinase 5 regulatory subunit?associated protein 1-like 1 (CDKAL1) gene. Here, weperformed a case-control study in the CDKAL1 gene (rs4712527 polymorphism) to investigate the potential association between this single-nucleotide polymorphism (SNP) and DR risk. Methods: Two hundred thirty-one patients with T2DM (126 patients with proliferative diabetic retinopathy [PDR] and 105 patients without diabetic retinopathy [WDR]), who assisted at the CentroPrivado de Ojos Romagosa, Fundacio´n VER, were studied. An independent cohort of 98 patients (56 with PDR and 42 with WDR) from the Hospital Nacional de Clı´nicas was taken for replication. A complete ophthalmological examination included an externalexamination of the eye and adnexa, pupil responsiveness, and slit-lamp biomicroscopic examination. Genotyping of rs4712527 was carried out by polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP). The odds ratio (OR) and 95% CI were calculated by unconditional logistic regression adjusted for diabetes duration, body mass index, insulin therapy,HbA1c, total cholesterol, high-density lipoprotein cholesterol, low-density lipoprotein cholesterol, triglycerides, and systolic and diastolic blood pressure. Results: Analysis from the rs4712527 SNP in the Centro Privado de Ojos Romagosa, Fundacio´n VER, cohort was found to be associated with decreased risk of PDR both before and after adjustment, under the codominant (adjustedOR ¼ 0.16 [95% CI, 0.06-0.44]; P ¼ 4e-04), dominant (adjusted OR ¼ 0.17 [95% CI, 0.07-0.43]; P ¼ 1e-04), overdominant (adjusted OR ¼ 0.20 [95% CI, 0.08-0.52]; P ¼ 5e-04), and log-additive (adjusted OR ¼ 0.28 [95% CI, 0.13-0.59]; P ¼ 4e-04)models. In the combined analysis including both cohorts, the rs4712527 was nominally involved as a protective factor in the development of DR. Conclusions: Our findings suggest that the rs4712527 in the CDKAL1 gene might be involved in the protection to develop PDR in T2DM.
Fil: Yang, Pablo. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Córdoba; Argentina. Universidad Católica de Córdoba. Facultad de Ciencias Químicas; Argentina. Area de Ciencias Agrarias, Ingeniería, Ciencias Biológicas y de la Salud de la Universidad Católica de Córdoba; Argentina
Fil: Luna, José Domingo. Fundaciòn Ver; Argentina
Fil: Alcoba, Emilio. Fundaciòn Ver; Argentina
Fil: Sein, Aylén. Fundaciòn Ver; Argentina
Fil: Gramajo, Ana Laura. Fundaciòn Ver; Argentina
Fil: Juárez, Claudio P.. Fundaciòn Ver; Argentina
Fil: Beltramo, Dante Miguel. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Córdoba; Argentina. Provincia de Córdoba. Ministerio de Ciencia y Técnica. Centro de Excelencia en Productos y Procesos de Córdoba; Argentina. Universidad Católica de Córdoba. Facultad de Ciencias Químicas; Argentina. Area de Ciencias Agrarias, Ingeniería, Ciencias Biológicas y de la Salud de la Universidad Católica de Córdoba; Argentina
Fil: Soria, Néstor Walter. Universidad Católica de Córdoba. Facultad de Ciencias Químicas; Argentina. Area de Ciencias Agrarias, Ingeniería, Ciencias Biológicas y de la Salud de la Universidad Católica de Córdoba; Argentina
description Purpose: Diabetic retinopathy (DR) is one of the chronic retinal disorders linked to diabetes and remains the leading cause of blindness in working-age people. Many studies have demonstrated the existence of associations between type 2 diabetes mellitus (T2DM) and variants in the cyclin-dependent kinase 5 regulatory subunit?associated protein 1-like 1 (CDKAL1) gene. Here, weperformed a case-control study in the CDKAL1 gene (rs4712527 polymorphism) to investigate the potential association between this single-nucleotide polymorphism (SNP) and DR risk. Methods: Two hundred thirty-one patients with T2DM (126 patients with proliferative diabetic retinopathy [PDR] and 105 patients without diabetic retinopathy [WDR]), who assisted at the CentroPrivado de Ojos Romagosa, Fundacio´n VER, were studied. An independent cohort of 98 patients (56 with PDR and 42 with WDR) from the Hospital Nacional de Clı´nicas was taken for replication. A complete ophthalmological examination included an externalexamination of the eye and adnexa, pupil responsiveness, and slit-lamp biomicroscopic examination. Genotyping of rs4712527 was carried out by polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP). The odds ratio (OR) and 95% CI were calculated by unconditional logistic regression adjusted for diabetes duration, body mass index, insulin therapy,HbA1c, total cholesterol, high-density lipoprotein cholesterol, low-density lipoprotein cholesterol, triglycerides, and systolic and diastolic blood pressure. Results: Analysis from the rs4712527 SNP in the Centro Privado de Ojos Romagosa, Fundacio´n VER, cohort was found to be associated with decreased risk of PDR both before and after adjustment, under the codominant (adjustedOR ¼ 0.16 [95% CI, 0.06-0.44]; P ¼ 4e-04), dominant (adjusted OR ¼ 0.17 [95% CI, 0.07-0.43]; P ¼ 1e-04), overdominant (adjusted OR ¼ 0.20 [95% CI, 0.08-0.52]; P ¼ 5e-04), and log-additive (adjusted OR ¼ 0.28 [95% CI, 0.13-0.59]; P ¼ 4e-04)models. In the combined analysis including both cohorts, the rs4712527 was nominally involved as a protective factor in the development of DR. Conclusions: Our findings suggest that the rs4712527 in the CDKAL1 gene might be involved in the protection to develop PDR in T2DM.
publishDate 2018
dc.date.none.fl_str_mv 2018-05
dc.type.none.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
http://purl.org/coar/resource_type/c_6501
info:ar-repo/semantics/articulo
format article
status_str publishedVersion
dc.identifier.none.fl_str_mv http://hdl.handle.net/11336/164341
Yang, Pablo; Luna, José Domingo; Alcoba, Emilio; Sein, Aylén; Gramajo, Ana Laura; et al.; The rs4712527 Polymorphism in the CDKAL1 Gene: A protective factor for proliferative diabetic retinopathy progress in type 2 diabetes; SAGE Publications; Journal of VitreoRetinal Diseases; 2; 4; 5-2018; 1-8
2474-1264
2474-1272
CONICET Digital
CONICET
url http://hdl.handle.net/11336/164341
identifier_str_mv Yang, Pablo; Luna, José Domingo; Alcoba, Emilio; Sein, Aylén; Gramajo, Ana Laura; et al.; The rs4712527 Polymorphism in the CDKAL1 Gene: A protective factor for proliferative diabetic retinopathy progress in type 2 diabetes; SAGE Publications; Journal of VitreoRetinal Diseases; 2; 4; 5-2018; 1-8
2474-1264
2474-1272
CONICET Digital
CONICET
dc.language.none.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv info:eu-repo/semantics/altIdentifier/url/http://journals.sagepub.com/doi/10.1177/2474126418777405
info:eu-repo/semantics/altIdentifier/doi/10.1177/2474126418777405
dc.rights.none.fl_str_mv info:eu-repo/semantics/openAccess
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
eu_rights_str_mv openAccess
rights_invalid_str_mv https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
dc.format.none.fl_str_mv application/pdf
application/pdf
application/pdf
application/pdf
dc.publisher.none.fl_str_mv SAGE Publications
publisher.none.fl_str_mv SAGE Publications
dc.source.none.fl_str_mv reponame:CONICET Digital (CONICET)
instname:Consejo Nacional de Investigaciones Científicas y Técnicas
reponame_str CONICET Digital (CONICET)
collection CONICET Digital (CONICET)
instname_str Consejo Nacional de Investigaciones Científicas y Técnicas
repository.name.fl_str_mv CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicas
repository.mail.fl_str_mv dasensio@conicet.gov.ar; lcarlino@conicet.gov.ar
_version_ 1844613577728589824
score 13.070432